Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	8.56	1.31	4.54	9.32	3.83
Short-Term Investments	6.22	0	0	0	4.56
Cash & Cash Equivalents	14.78	1.31	4.54	9.32	8.39
Cash Growth	1026.22%	-71.10%	-51.28%	10.99%	-
Other Current Assets	0.69	0.14	0.19	0.16	0.26
Total Current Assets	15.46	1.45	4.73	9.48	8.65
Property, Plant & Equipment	0.15	0.14	0.32	0.49	0.25
Other Long-Term Assets	1.68	0.17	0.17	0.18	0.03
Total Long-Term Assets	1.83	0.31	0.49	0.67	0.28
Total Assets	17.3	1.76	5.22	10.15	8.93
Accounts Payable	3.05	0.6	0.17	0.22	0.39
Current Debt	0	4.35	2.2	0.17	0.12
Other Current Liabilities	0.91	1.87	1.35	0.95	0.62
Total Current Liabilities	3.96	6.82	3.72	1.35	1.13
Long-Term Debt	0.14	0	0.14	0.33	0.14
Other Long-Term Liabilities	0.04	0.04	0.04	0.04	0.04
Total Long-Term Liabilities	0.17	0.04	0.18	0.36	0.18
Total Liabilities	4.13	6.86	3.9	1.71	1.31
Total Debt	0.14	4.35	2.34	0.5	0.26
Debt Growth	-96.83%	85.64%	370.91%	91.14%	-
Retained Earnings	-50.52	-38.65	-31.07	-23.18	-17.15
Shareholders' Equity	13.16	-15.1	-8.68	-1.56	-2.38
Net Cash / Debt	14.64	-3.04	2.2	8.82	8.13
Net Cash / Debt Growth	-	-	-75.09%	8.42%	-
Net Cash Per Share	1.70	-0.89	0.64	2.59	2.39
Working Capital	11.51	-5.37	1.01	8.13	7.52
Book Value Per Share	1.53	-4.43	-2.55	-0.46	-0.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).